Pierre Storck

Statistics

Publications

Citations

105

H-Index

Active since

2005

Affiliations

Vertex Pharmaceuticals (United Kingdom)(Current)

Pierre Storck is an author at Vertex Pharmaceuticals (United Kingdom) specializing in pharmacy, medicinal chemistry, and dna damage response pathways.

Publications per year

2005–2019

Publications

Rational Design of 5-(4-(Isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine (VX-970, M6620): Optimization of Intra- and Intermolecular Polar Interactions of a New Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase Inhibitor

Ronald M. A. Knegtel, Jean‐Damien Charrier, Steven J. Durrant et al. · Journal of Medicinal Chemistry · 2019 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

Tosylation/mesylation of 4-hydroxy-3-nitro-2-pyridinones as an activation step in the construction of dihydropyrido[3,4-b] benzo[f][1,4]thiazepin-1-one based anti-HIV agents

Pierre Storck, Anné-Marie Aubertin, David S. Grierson · Tetrahedron Letters · 2005 · 51 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

1–2 of 2